{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Artelo Biosciences, Inc.
Is Artelo Biosciences, Inc. technically bullish or bearish?
As of June 17, 2025, the trend is bullish with strong indicators like the weekly MACD and Bollinger Bands, but caution is advised due to bearish RSI readings on both weekly and monthly time frames.
What does Artelo Biosciences, Inc. do?
Artelo Biosciences, Inc. is a biopharmaceutical company focused on developing treatments that modulate the endocannabinoid system. It has a market cap of $3.42 million and reported a net profit loss of $2 million as of March 2025.
How big is Artelo Biosciences, Inc.?
As of Jun 18, Artelo Biosciences, Inc. has a market capitalization of 3.42 million, with net sales of 0.00 million and a net profit of -9.71 million over the latest four quarters. Shareholder's funds are 2.86 million, and total assets amount to 4.70 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
